| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.57 | 0.03 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |